Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.49 |
| ▸ | GRB2 | P62993 | 1/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.44 |
| ▸ | NTSR2 | O95665 | 13/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 13/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 12/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.42 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30631327 | 0.93 | XIAP (0.52) | XIAPANPEPLNPEPGRB2CAPN1 | |
| SCHEMBL14693963 | 0.91 | XIAP (0.53) | XIAPANPEPLNPEPNTSR2NTSR1 | |
| SCHEMBL14693960 | 0.91 | XIAP (0.53) | XIAPANPEPLNPEPNTSR2NTSR1 | |
| SCHEMBL30874709 | 0.90 | XIAP (0.53) | XIAPANPEPLNPEPGRB2NTSR2 | |
| SCHEMBL31289489 | 0.89 | XIAP (0.52) | XIAPNTSR2NTSR1SORT1AGTR1 | |
| SCHEMBL31461973 | 0.87 | XIAP (0.52) | XIAPANPEPLNPEPCAPN1NTSR2 | |
| Davunetide SCHEMBL239737 | 0.87 | XIAP (0.48) | XIAPNTSR2NTSR1SORT1F2 | |
| Davunetide SCHEMBL19712227 | 0.87 | XIAP (0.48) | XIAPNTSR2NTSR1SORT1F2 | |
| Davunetide SCHEMBL239736 | 0.87 | XIAP (0.48) | XIAPNTSR2NTSR1SORT1F2 | |
| Davunetide SCHEMBL3689039 | 0.87 | XIAP (0.48) | XIAPNTSR2NTSR1SORT1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313117-A1 | USE OF ADNF POLYPEPTIDES IN THERAPY | Ramot at Tel-Aviv University Ltd. (IL) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022201167-A1 | USE OF ADNF POLYPEPTIDES IN THERAPY | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-09-29 | — | — | WO | disclosed |